Puma Biotechnology Inc (NAS:PBYI)
$ 2.991 -0.219 (-6.82%) Market Cap: 146.70 Mil Enterprise Value: 158.75 Mil PE Ratio: 16.62 PB Ratio: 2.99 GF Score: 56/100

Q4 2020 Puma Biotechnology Inc Earnings Call Transcript

Feb 25, 2021 / 09:30PM GMT
Release Date Price: $10.55 (-6.72%)
Operator

Good afternoon. My name is Donna, and I will be your conference operator today. Welcome to the Puma Biotechnology conference call. (Operator Instructions) And as a reminder, this conference is being recorded.

I would now like to turn the conference over to Ms. Mariann Ohanesian, Senior Director of IR for Puma Biotechnologies. Thank you. Please go ahead.

Mariann Ohanesian
Puma Biotechnology, Inc. - Senior Director of IR

Thank you, Donna. Good afternoon and welcome to Puma's conference call to discuss our financial results for the fourth quarter of 2020.

Joining me on the call today are Alan Auerbach, Chief Executive Officer, President and Chairman of the Board of Puma Biotechnology; Maximo Nougues, Chief Financial Officer; and Jeff Ludwig, Chief Commercial Officer.

After market closed today, Puma issued a news release detailing fourth quarter 2020 financial results. That news release, the slides that Jeff will refer to and a webcast of this call are accessible via the homepage and Investors sections of our website at

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot